Boiron SA is a global healthcare company specializing in the development, manufacture, and distribution of homeopathic products. Established in 1932, Boiron has grown into the world’s largest manufact... Boiron SA is a global healthcare company specializing in the development, manufacture, and distribution of homeopathic products. Established in 1932, Boiron has grown into the world’s largest manufacturer in its sector, offering a broad array of homeopathic remedies and over-the-counter specialties designed for various symptoms and health conditions. Its portfolio includes well-known products such as Oscillococcinum, Arnigel, Camilia, and Stodal, serving consumers seeking non-conventional healthcare options. Boiron operates in nearly 50 countries and maintains a substantial market presence, with most of its revenue generated in France, but also significant operations across Europe, North America, and additional international markets. The company emphasizes stringent manufacturing standards, adhering to regulatory frameworks where required, and centralizes its production and logistics in France. Within the financial market, Boiron SA is classified in the specialty and generic drug manufacturing sector, with a distinctive focus on alternative medicine. The company plays a notable role in promoting homeopathic practices worldwide, contributing to the diversification of health and wellness offerings in the broader pharmaceutical industry.